Objective: Spinal cord ischemia/reperfusion injury involves multiple factors that may be modulated by adenosine A 2A receptor activation. This study defines injury progression in terms of function, cytoarchitecture, and inflammation and assesses whether adenosine A 2A receptor activation by ATL-146e limits injury progression.
P araplegia remains a significant risk for up to 20% of patients undergoing thoracic and thoracoabdominal aortic interventions. 1 Although neuroprotective strategies for these patients are emerging, no pharmacologic interventions have been adequate for use in patients to prevent ischemic spinal cord injury. 2 Previous studies have suggested that adenosine A 2A receptor activation may modulate several aspects of spinal cord ischemia/reperfusion (IR) injury. A 2A activation suppresses the inflammatory response to traumatic brain injury by suppressing leukocyte recruitment and by reducing cytokine release, most notably tumor necrosis factor (TNF)-␣ and interleukin-1. Spinal cord IR injury involves apoptotic death of neurons and white matter damage after injury, which can be further exacerbated by secondary inflammation. 3 Adenosine A 2A receptor-mediated suppression of inflammation may also limit this process of neuronal degeneration.
Previous studies using ATL-146e to activate the adenosine A 2A receptor in animal models have shown that systemic adenosine A 2A receptor activation can prevent functional impairment after temporary aortic occlusion. [4] [5] [6] [7] Other studies suggested that adenosine A 2A receptor activation reduced systemic TNF-␣ levels and preserved spinal cord histology within the first 48 hours. 8 However, the progression of spinal cord IR injury with respect to function, local and regional inflammation, and cytoarchitecture has not been examined. Moreover, the effect of adenosine A 2A receptor activation on spinal cord IR injury progression is not known.
In this study, we evaluated the effect of adenosine A 2A receptor activation on the progression of spinal cord IR injury in terms of inflammation, neuronal cytoarchitecture, and function. We attempted to define the progression of cytoarchitectural damage over the first 48 hours by using neuronal viability scoring and microtubule-associated protein-2 (MAP-2) staining, a sensitive marker of ischemic neuronal injury. 9 Additionally, we defined the progression of the local inflammatory response by focusing on neutrophil sequestration and TNF-␣ concentration, not only systemically in serum, but also regionally in cerebrospinal fluid (CSF) and locally in neuronal tissue. Finally, we observed a group of treated animals for 1 week after injury to determine whether the benefit in motor function is preserved over time.
Methods
All protocols were reviewed and approved by the Animal Care and Use Committee of the University of Virginia before the study began. All animals received humane care in compliance with the "Guide for the Care and Use of Laboratory Animals" (Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, 1996).
Mature domestic swine were separated into 3 groups. Sham, ATL-treated, and IR control groups underwent the following procedures before they were killed at specific time points for procurement of serum, CSF, and tissue.
Procedures
Domestic pigs were anesthetized with intramuscular ketamine (50 mg/kg) and xylazine (1 mg/kg). Pigs were intubated before connection to a volume ventilator (respiratory rate of 14 breaths/min and tidal volume of 250 mL). Anesthesia was maintained with vaporized halothane. The arterial pressure was monitored with a pressure transducer (Hewlett-Packard, Palo Alto, Calif). Maintenance fluids were given at 100 mL/h. The animals' temperatures were maintained at 36°C for the procedure by using a heating pad.
Through a left lateral thoracotomy, the distal aortic arch and descending aorta was exposed. After systemic heparinization (heparin sulfate 200 U/kg), a crossclamp was placed on the descending aorta distal to the left subclavian artery takeoff. The crossclamp was left in place for 30 minutes before the distal aorta was reperfused in the IR control animals. After reperfusion and hemostasis, the chest was closed. The animals were then allowed to emerge from anesthesia. Sham animals underwent the entire procedure except for the aortic occlusion. ATL-146e-treated animals (ATL group) underwent the IR procedure in addition to ATL-146e (0.06 g · kg Ϫ1 · min Ϫ1 IV) beginning 10 minutes before reperfusion and continuing for 3 hours. This dose of ATL was established in previous studies as optimal for ischemic spinal cord preservation. 6 The animals were killed at specific times of reperfusion. Eight animals in each group at each time point were killed at the onset of reperfusion (sham and IR only) and then at 3, 6, 12, 24, and 48 hours after reperfusion (n ϭ 136). Four more ATL animals were observed for 7 days to evaluate for any functional decompensation.
Functional Assessment
Functional status was graded by a blinded observer using the Tarlov scale. 10 Scores range from 0 to 5 and are based on hind limb movement. No hind limb movement meant a score of 0. Some movement meant a score of 1. Animals able to sit with assistance were graded as 2. Animals able to sit alone received a score of 3. Animals with an unsteady gait received a score of 4. Animals with a normal gait received a score of 5. Functional scores were taken at 12, 24, 36, and 48 hours. The 7-day survivors were graded once a day after the first 48 hours for the final 5 days.
Tissue
At the given time points, the animals were again anesthetized with ketamine and xylazine. Serum and CSF samples were obtained. After animals were killed, the left side of the chest was reopened. The descending aorta was excised to confirm that the crossclamp occluded the highest spinal artery. Any animal clamped below this branch was excluded from the study, regardless of group, because this critical spinal vessel can potentially preserve blood flow to the spinal cord. Next, the lumbar spinal cord was extracted to be fixed for histology and flashfrozen for molecular studies. 
ACD

Tumor Necrosis Factor-␣
Lumbar spinal cord lysate was generated from a minimum of 5 mg of tissue sample in Triton X-100 lysis buffer (Sigma-Aldrich Corp, St Louis, Mo) by using a tissue homogenizer (Fisher Scientific International, Pittsburgh, Pa). The lysis buffer consisted of 1% Triton X-100, 20 mmol/L Tris (pH 7.4; Sigma-Aldrich), 150 mmol/L NaCl (Sigma-Aldrich), 1 mmol/L ethylenediaminetetraacetic acid (SigmaAldrich), leupeptin 2 g/mL (Roche Diagnostics Corp, Indianapolis, Ind), pepstatin 0.7 g/mL (Roche), chymostatin 100 mol/L (Roche), and antipain 100 mol/L (Roche). After centrifuging at 10,000 RPM at 0°C for 10 minutes, the supernatant was aspirated and frozen. TNF-␣ levels of spinal cord tissue lysates, CSF, and serum were determined by a commercially available enzyme-linked immunosorbent assay (ELISA) kit (Pierce Biotechnology Inc, Rockford, Ill) according to the manufacturer's protocols. All samples were tested in duplicate and averaged. The ELISA kit sensitivity for TNF-␣ was 20 pg/mL. All readings were performed on an MRX II absorbance reader (DYNEX Technologies Inc, Chantilly, Va). The TNF-␣ concentration was expressed in picograms per milliliter.
Myeloperoxidase
Neutrophil sequestration in the spinal cord was quantified with a myeloperoxidase (MPO) assay. Spinal cord tissue that had been 
Neuronal Viability
Five-micrometer sections of formalin-fixed samples were stained with hematoxylin and eosin. Semiserial sections from the midthoracic spinal cord were counted in blinded fashion for the number of viable ventral horn motor neurons by using standard criteria. The mean number of intact motor neurons was quantitated for comparison.
MAP-2 Immunohistochemistry
Ten-micrometer sections of formalin-fixed samples were mounted on slides and deparaffinized in xylenes and progressive alcohol rinses. In preparation for immunocytochemistry, sections were processed by using a temperature-controlled microwave antigenretrieval approach described previously in detail. 11 Endogenous peroxidase was blocked by incubation in a solution of 1.65% H 2 O 2 in 0.025% Triton X in Tris-buffered saline (TBS). Sections were incubated overnight in mouse anti-MAP-2 antibody (clone MT-01; Abcam Ltd, Cambridge, United Kingdom) at a dilution of 1:100 in TBS with 1% bovine serum albumin before they were rinsed in TBS/Triton X and incubated for 2 hours in biotinylated anti-mouse immunoglobulin G (1:200; Vector, Burlingame, Calif) in TBS with 1% bovine serum albumin. After incubation in an avidin-biotin-peroxidase complex (ABC standard Elite kit; Vector; dilution of 1:100), and sections were processed for visualization of the immunohistochemical complex by 0.05% diaminobenzidine (Sigma-Aldrich) and 0.01% hydrogen peroxide.
The percentage of gray matter stained positively for MAP-2 within injured spinal cord was quantified and statistically compared among treatment groups and control animals. Semiserial spinal cord sections reacted for MAP-2 were examined with a microscope interfaced with a charge-coupled device digital camera and computer image analysis system (VisionGauge Image Analysis software; VISIONx Inc, Pointe Claire, Quebec, Canada). Images of spinal cord sections were captured and digitized. Gray matter was outlined in the VisionGauge system, and background staining thresholds were calculated in adjacent white matter tissue for each section. The percentage of gray matter tissue staining positively above background thresholds were then calculated by the VisionGauge software. The mean percentage of MAP-2 gray matter staining was thus calculated for each animal.
Statistics
The statistics were analyzed by our statistician, who used analysis of variance with Bonferroni multiple comparison tests to determine significant differences. A nonparametric analysis provided the same conclusions as the analysis of variance.
Results
Hind Limb Function
Functional outcomes, quantified by Tarlov scores, showed a trend toward preservation in ATL compared with IR ani- mals at 12 hours, and this became significant by 24 hours and continued to be significant at 36 and 48 hours. 
Neutrophil Sequestration
The spinal cord MPO assay demonstrated no differences in neutrophil sequestration among groups at 12 hours. By 24 and 48 hours, however, the MPO was significantly lower in sham and ATL animals compared with IR animals (Figure 2 ).
TNF-␣
Serum and CSF concentrations of TNF-␣ remained below the reliably detectable limits of the ELISA preparation. Although a significantly different bimodal peak of TNF-␣ in these compartments was noted in the IR group, the implications of these findings can only be speculated at such low levels. 
ACD
In spinal cord tissue depicted in Figure 3 , TNF-␣ concentrations were similarly low at reperfusion and 3 hours later among all 3 groups. By 6 hours after reperfusion, spinal cord TNF-␣ in sham and ATL animals remained low, with significantly higher levels in IR animals. At 12 hours, the spinal cord TNF-␣ concentration leveled off in IR animals, only to peak again at 24 hours in all 3 groups.
Neuronal Viability
Spinal cord tissue from sham animals demonstrated normal gray and white matter cytoarchitecture, with large pyramidal ventral horn motor nuclei and prominent nucleoli. Tissue from ATL-treated animals demonstrated mild cytoarchitectural derangement, whereas IR animals had markedly abnormal spinal cords with vacuolization of parenchyma and multiple pyknotic neuronal somata.
Neuronal viability demonstrated no significant differences among groups at 12 hours of reperfusion. By 24 hours of reperfusion, significantly fewer viable neurons per highpower field were noted in IR animals compared with the sham and ATL groups. By 48 hours of reperfusion, neuronal viability deteriorated in the IR group compared with the other 2 groups. Neuronal viability, assessed by neurons per high-power field in ventral horn gray matter, in the first 48 hours is shown in Figure 4 .
MAP-2 Immunohistochemistry
After 6 hours of reperfusion, the MAP-2 expression (percentage stained in gray matter) remained nearly identical among the 3 groups. By 12 hours, IR animals had significantly less MAP-2 expression compared with sham, but they were still not different from the ATL animals. By 24 hours of reperfusion, MAP-2 expression was significantly different among all 3 groups. At 48 hours, MAP-2 expression was again significantly different among all 3 groups. MAP-2 expression in the first 48 hours is shown in Figure 5 .
Discussion
Various pharmacologic agents have been studied with the goal of attenuating ischemic spinal cord injury, but their utility in patients remains controversial.
2 Improved understanding about injury progression and the role of inflammation in this process would permit the identification of novel strategies to limit IR injury. Our laboratory has demonstrated a potential therapeutic benefit of adenosine in this context. 10, 12 However, adenosine requires a hypothermic carrier and local delivery, which restricts its use. 13 Improved understanding of the mechanism of action of adenosine has elucidated the role of specific adenosine receptors. Systemic adenosine A 2A receptor activation has attenuated injury in a rabbit model of spinal cord ischemia. 7 This study demonstrates the attenuation of injury progression by adenosine A 2A receptor activation from 3 different perspectives of IR injury in the spinal cord. Tarlov scores were used to evaluate and follow up functional impairment. Neuronal cytoarchitecture was observed by using both neuronal viability scoring and the extent of MAP-2 expression. Finally, inflammation was assessed both by observing TNF-␣ in systemic, regional, and local compartments and by evaluating neutrophil sequestration in spinal cord tissue. Evaluation of these variables over time provides important insights into the interplay among these factors in both the progression and prevention of spinal cord IR injury.
The trend toward functional preservation with ATL therapy became statistically significant at 24 hours of reperfusion, at which time both sham and ATL animals had higher Tarlov scores than IR animals. This difference was sustained at 48 hours after reperfusion. The ATL group observed with longer evaluation preserved their 24-hour functional scores through 7 days, indicating that no deterioration of motor function arose subacutely among treated animals.
The study also demonstrated differences among groups in the progression of cytoarchitectural injury. Although differences in MAP-2 became notable by 12 hours after reperfusion between 2 of the groups, the differences in MAP-2 expression between the IR group and the other 2 groups did not become significant until 24 hours after reperfusion. By 48 hours after reperfusion, significant differences arose among all 3 groups, including significant differences between the sham group and the ATL group. Neuronal viability became significant after 24 hours of reperfusion between the IR group and the other 2 groups, and this continued through 48 hours after reperfusion. These findings demonstrate that histologic and immunohistochemical evidence of injury is not immediate and is preceded by detectable differences in motor functioning.
By comparing the inflammatory response to IR injury in other organ systems with the results of this study, interesting parallels are identified. 14 Cassada and colleagues 8 demonstrated reduced serum TNF-␣ concentrations by adenosine A 2A receptor activation after temporary aortic occlusion in rabbits. The current study expanded on this finding by evaluating local, regional, and systemic inflammatory responses to spinal cord IR injury. Our current study did not demonstrate appreciable concentrations of TNF-␣ in serum or CSF to allow speculation about the systemic-or even regional-inflammatory response to this injury. The higher tissue concentrations showed a similar pattern that suggested a bimodal release of TNF-␣ after IR. Spinal cord tissue from the IR group demonstrated a significant increase in tissue TNF-␣ by 6 hours of reperfusion compared with the ATL and sham groups. Although IR spinal cord tissue TNF-␣ levels seemed to plateau after 12 hours of reperfusion, by 24 hours after reperfusion, the level peaked at a higher concentration in all 3 groups, which was significantly higher in IR animals compared with ATL and sham animals.
This bimodal peak in tissue TNF-␣ concentration was not predicted, but similar observations have been made at earlier time points in pulmonary IR injury. [15] [16] [17] These studies concluded that the resident macrophages were responsible for early inflammation, which is followed with more vigor by the neutrophil response to the IR injury. Because the spinal cord harbors no resident leukocytes, the early peak in tissue TNF-␣ in our study may derive from microglia, which precipitate the neutrophil response and lead to amplification of inflammation after 24 hours of reperfusion. This did coincide with the significant increase in neutrophil sequestration in the IR group. This finding supports the conclusion from other organ models of IR that describe early local cellular inflammation trailed by a later, more intense neutrophil-derived inflammatory response.
This study demonstrated that ATL-146e attenuated the inflammatory response to IR in the spinal cord, but it did not identify the attenuating mechanism. The study demonstrated both inflammatory attenuation and functional preservation, but the exact relationship between the 2 remains unknown. The study does not exclude the possibility that inflammation is impaired by adenosine A 2A receptor activation because of direct neuroprotective effects that limit initial spinal cord neuronal injury. Other authors have argued that early intervention remains the best chance for functional preservation after spinal cord injury in both vascular surgery and blunt spinal cord trauma. 18 The benefit of pharmacologic protection with ATL-146e may be optimized with the initiation of therapy at reperfusion. Preventive strategies are already being exploited with lumbar CSF drainage, regional cooling, and distal perfusion techniques.
19-21 ATL-146e clearly preserves spinal cord function and neuronal cytoarchitecture and attenuates the inflammatory response after IR. The protective mechanisms are not fully understood, but animals maintain function despite ischemic insult.
In conclusion, this study demonstrated optimal time points for studies of differences in function, inflammation, and neuronal cytoarchitecture. Most notably in this study and in patients undergoing transient thoracic aortic occlusion who might avoid distal bypass or lumbar drain placement, adenosine A 2A receptor activation attenuates every aspect of injury measured, including markers of hind limb function, neuronal cytoarchitecture, and inflammation.
